Home Micronoma

Micronoma

In operation
Debt Financing
Cancer Detection Technology and Product Developer

Basic Information

Micronoma is the first cancer detection company to use liquid biopsy technology to detect and predict cancer by querying microbial signals with clinical-grade accuracy in the early stages of disease. Micronoma can detect and differentiate microbes in the blood and predict whether a patient is cancer-free or has a specific type of cancer. A liquid biopsy is a test performed on a blood sample to look for circulating tumor cells (CTCs) or DNA that have shed from a tumor. Liquid biopsies may help in the early detection of cancer.
Micronoma Inc.
SanDiego,California,United States of America
less than 15 people
June 01, 2019
info@micronoma.com